Abstract

Covalent conjugation of allergens to toll-like receptor (TLR) agonists appears to be a powerful strategy for the development of safety compounds for allergen-specific immunomodulatory response toward tolerance in allergy. In this work, we have synthesized two family of ligands, an 8-oxoadenine derivative as a ligand for TLR7 and a pyrimido[5,4-b]indole as a ligand for TLR4, both conjugated with a T-cell peptide of Pru p 3 allergen, the lipid transfer protein (LTP) responsible for LTP-dependent food allergy. These conjugates interact with dendritic cells, inducing their specific maturation, T-cell proliferation, and cytokine production in peach allergic patients. Moreover, they increased the Treg-cell frequencies in these patients and could induce the IL-10 production. These outcomes were remarkable in the case of the TLR7 ligand conjugated with Pru p 3, opening the door for the potential application of these allergen–adjuvant systems in food allergy immunotherapy.

Highlights

  • Food allergy (FA) is currently a burden for the Health Systems mainly in western European countries where the prevalence is increasing with plant origin as the main triggers in both adult and adolescent populations.[1]

  • We have addressed the immunological response induced by compounds that include, besides the TLR4 or TLR7 agonists, a synthetic peptide of the allergenic epitope Pru p 3 (Pp3), TLR4lig-Pp3, and TLR7lig-Pp3, respectively, in cells from lipid transfer protein (LTP) allergic patients and analyzed the type of response in order to assess the modulatory capacity of these ligands

  • We have focused our efforts to prepare a TLR4 agonist based on pyrimido[5,4-b]indole derivatives

Read more

Summary

Introduction

Food allergy (FA) is currently a burden for the Health Systems mainly in western European countries where the prevalence is increasing with plant origin as the main triggers in both adult and adolescent populations.[1]. Novel vaccines that overcome such inconveniences are in demand

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call